Animal Models of Chronic Migraine: From the Bench to Therapy
- PMID: 38954246
- DOI: 10.1007/s11916-024-01290-y
Animal Models of Chronic Migraine: From the Bench to Therapy
Abstract
Purpose of review: Chronic migraine is a disabling progressive disorder without effective management approaches. Animal models have been developed and used in chronic migraine research. However, there are several problems with existing models. Therefore, we aimed to summarize and analyze existing animal models to facilitate translation from basic to clinical.
Recent findings: The most commonly used models are the inflammatory soup induction model and the nitric oxide donor induction model. In addition, KATP openers have also been used in model induction. Based on the above models, some molecular targets have been identified, such as glutamate receptors. However, each model has its shortcomings and characteristics, and there are still some common problems that need to be solved, such as spontaneous headache, evaluation criteria after model establishment, and identification methods. In this review, we summarized and highlighted the advantages and limitations of the currently commonly used animal models of chronic migraine with a special focus on drug discovery and current therapeutic strategies, and discussed the directions that can be worked on in the future.
Keywords: Animal models; Chronic migraine; Headache; Therapeutic medicine.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Animal Models of Chronic Migraine.Curr Pain Headache Rep. 2018 May 19;22(6):44. doi: 10.1007/s11916-018-0693-5. Curr Pain Headache Rep. 2018. PMID: 29779126 Review.
-
Nitric oxide in migraine.CNS Neurol Disord Drug Targets. 2007 Aug;6(4):258-64. doi: 10.2174/187152707781387233. CNS Neurol Disord Drug Targets. 2007. PMID: 17691982 Review.
-
An underrepresented majority: A systematic review utilizing allodynic criteria to examine the present scarcity of discrete animal models for episodic migraine.Cephalalgia. 2021 Mar;41(3):404-416. doi: 10.1177/0333102420966984. Epub 2020 Nov 1. Cephalalgia. 2021. PMID: 33131303 Free PMC article.
-
Characterization of a novel model of chronic migraine.Pain. 2014 Feb;155(2):269-274. doi: 10.1016/j.pain.2013.10.004. Epub 2013 Oct 10. Pain. 2014. PMID: 24121068 Free PMC article.
-
Animal models of chronic migraine.Curr Pain Headache Rep. 2015 Jan;19(1):467. doi: 10.1007/s11916-014-0467-7. Curr Pain Headache Rep. 2015. PMID: 25416460 Review.
Cited by
-
[Huoxue Shufeng Granule alleviates central sensitization in chronic migraine mice via TLR4/NF-κB inflammatory pathway].Nan Fang Yi Ke Da Xue Xue Bao. 2025 May 20;45(5):986-994. doi: 10.12122/j.issn.1673-4254.2025.05.11. Nan Fang Yi Ke Da Xue Xue Bao. 2025. PMID: 40415430 Free PMC article. Chinese.
References
-
- Ferrari MD, Goadsby PJ, Burstein R, et al. Migraine. Nat Rev Dis Primers. 2022;8(1):2. Published 2022 Jan 13. https://doi.org/10.1038/s41572-021-00328-4 .
-
- Schwedt TJ. Chronic migraine. BMJ. 2014;348:g1416. Published 2014 Mar 24. https://doi.org/10.1136/bmj.g1416 .
-
- Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631–49. https://doi.org/10.1016/j.ncl.2019.06.001 . - DOI - PubMed
-
- Zobdeh F, Ben Kraiem A, Attwood MM, et al. Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments. Br J Pharmacol. 2021;178(23):4588–607. https://doi.org/10.1111/bph.15657 . - DOI - PubMed
-
- Kuruvilla DE, Bilchik T. Preventing the Progression of Episodic Migraine to Chronic Migraine with Acute Treatment Optimization. Curr Pain Headache Rep. 2022;26(3):253–8. https://doi.org/10.1007/s11916-022-01022-0 . - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials